Serum and CSF Biomarkers Predict Active Early Cognitive Decline Rather Than Established Cognitive Impairment at the Moment of RRMS Diagnosis

(1) Background: Cognitive impairment (CI) begins early in the evolution of multiple sclerosis (MS) but may only become obvious in the later stages of the disease. Little data is available regarding predictive biomarkers for early, active cognitive decline in relapse remitting MS (RRMS) patients. (2)...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiu, Vlad Eugen, Popescu, Bogdan Ovidiu, Enache, Iulian Ion, Tiu, Cristina, Terecoasa, Elena, Panea, Cristina Aura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689215/
https://www.ncbi.nlm.nih.gov/pubmed/36359416
http://dx.doi.org/10.3390/diagnostics12112571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689215/
https://www.ncbi.nlm.nih.gov/pubmed/36359416
http://dx.doi.org/10.3390/diagnostics12112571

Ejemplares similares